Management of emerging multidrug-resistant tuberculosis in a low-prevalence setting - CNRS - Centre national de la recherche scientifique Accéder directement au contenu
Article Dans Une Revue Clinical Microbiology and Infection Année : 2015

Management of emerging multidrug-resistant tuberculosis in a low-prevalence setting

N. Freymond
  • Fonction : Auteur
Lyon Tb Study Group
  • Fonction : Auteur

Résumé

Multidrug-resistant (MDR) tuberculosis (TB) is an emerging concern in communities with a low TB prevalence and a high standard of public health. Twenty-three consecutive adult MDR TB patients who were treated at our institution between 2007 and 2013 were reviewed for demographic characteristics and anti-TB treatment management, which included surgical procedures and long-term patient follow-up. This report of our experience emphasizes the need for an individualized approach as MDR TB brings mycobacterial disease management to a higher level of expertise, and for a balance to be found between international current guidelines and patient-tailored treatment strategies.

Dates et versions

hal-01911481 , version 1 (02-11-2018)

Identifiants

Citer

G. Catho, S. Couraud, S. Grard, A. Bouaziz, A. Sénéchal, et al.. Management of emerging multidrug-resistant tuberculosis in a low-prevalence setting. Clinical Microbiology and Infection, 2015, 21 (5), pp.472.e7-10. ⟨10.1016/j.cmi.2014.12.022⟩. ⟨hal-01911481⟩
20 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More